Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands

Oral Oncology

Volumn 42, Issue 2, 2006, Pages 154-160

  Genelhu, Marisa Cristina Leite Santos ^a,c   Gobbi, Helenice ^a   Soares, Fernando Augusto ^b   Campos, Antônio Hugo José Froes De Marques ^b   Ribeiro, Carlos Alberto ^a   Cassali, Geovanni Dantas ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

Author keywords

Carcinoma ex pleomorphic adenoma; Immunohistochemistry; p63; Pleomorphic adenoma; Salivary gland tumor

Indexed keywords

MONOCLONAL ANTIBODY; P63 ANTIBODY; PROTEIN P63; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PARENCHYMA; PHENOTYPE; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SALIVARY GLAND TUMOR;

ADENOMA, PLEOMORPHIC; ADULT; AGED; CARCINOMA; CELL DIFFERENTIATION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SALIVARY GLAND NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 30944465531     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.06.026     Document Type: Article

References (37)

1. C.J. Di Como, M.J. Urist, I. Babayan, M. Drobnjak, C.V. Hedvat, and J. Teruya-Felstein p63 expression profiles in human normal and tumor tissues Clin Cancer Res 8 2002 494 501
2. A. Weber, L. Langhanki, and A. Schütz Expression profiles of p53, p63, and p73 in benign salivary gland tumors Virchows Arch 441 2002 428 436
3. J.S. Reis-Filho, and F.C. Schmitt Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker Adv Anat Pathol 9 5 2002 280 289
4. H. Bilal, A. Handra-Luca, J.C. Bertrand, and P.J. Fouret p63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues J Histochem Cytochem 51 2003 133 139
5. M. Bortoluzzi, L.S. Yurgel, N.P. Dekker, R.C.K. Jordan, and J.A. Regezi Assessment of p63 expression in oral squamous cell carcinomas and dysplasias Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 6 2004 698 704
6. M. Barbareschi, L. Pecciarini, M.G. Cangi, E. Macr, A. Rizzo, and G. Viale p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast Am J Surg Pathol 25 8 2001 1054 1060
7. R.W. Werling, H. Hwang, H. Yaziji, and A.M. Gown Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain Am J Surg Pathol 27 1 2003 82 90
8. J.S. Reis-Filho, B. Torio, A. Albergaria, and F. Schmitt p63 expression in normal skin and usual cutaneous carcinomas J Cutan Pathol 29 2002 517 523
9. B.J. Park, S.J. Lee, J.I. Kim, S.J. Lee, C.H. Lee, and S.G. Chang Frequent alteration of p63 expression in human bladder carcinomas Cancer Res 60 2000 3370 3374
10. G. Seifert, and L.H. Sobin WHO International classification of tumors. Histological Typing of Salivary Gland Tumors 2nd Ed. 1991 Spring-Verlag Berlin Heidelberg
11. G.L. Ellis, and P.L. Auclair Tumors of the salivary glands. Atlas of tumor pathology 3rd Ed. 1996 Armed Forces Institute of Pathology Washington, DC
12. D.R. Gnepp Malignant mixed tumors of the salivary glands: a review Pathol Annu 28 Pt 1 1993 279 328
13. V.A. Li Volsi, and K.H. Perzin Malignant mixed tumors arising in salivary glands. 1. Carcinomas arising in benign mixed tumors: a clinicopathologic study Cancer 39 1977 2209 2230
14. R.H. Spiro, A.G. Huvos, and E.W. Strong Malignant mixed tumor of salivary origin. A clinicopathologic study of 146 cases Cancer 39 1977 388 396
15. S. Said, and J. Campana Myoepithelial carcinoma ex pleomorphic adenoma of salivary glands: a problematic diagnosis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 2005 196 201
16. R. Singh, and R.A. Cawson Malignant myoepithelial carcinoma (myoepithelioma) arising in a pleomorphic adenoma of the parotid gland. An immunohistochemical study and review of the literature Oral Surg Oral Med Oral Pathol 66 1 1988 65 70
17. J.E. Lewis, K.D. Olsen, and T.J. Sebo Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases Hum Pathol 32 2001 596 604
18. K.D. Olsen, and J.E. Lewis Carcinoma ex pleomorphic adenoma: a clinicopathologic review Head Neck 23 9 2001 705 712
19. P.L. Auclair, and G.L. Ellis Atypical features in salivary gland mixed tumors: their relationship to malignant transformation Mod Pathol 9 6 1996 652 657
20. M.E. Tortolodo, M.A. Luna, and J.G. Batsakis Carcinomas ex-pleomorphic adenoma and malignant mixed tumors. Histomorfologic indexes Arch Otolaryngol 110 3 1984 172 176
21. P.D. Righi, and Y.Q. Li The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland Anticancer Res 14 5B 1994 2253 2257
22. J. Costa-Rosa, I. Fonseca, A. Félix, and J. Soares Immunohistochemical study of c-erbB-2 expression in carcinoma ex-pleomorphic adenoma Histopathology 28 1996 247 252
23. E. Röijer, A. Nordkvist, A.K. Ström, W. Ryd, M. Behrendt, and J. Bullerdiek Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma Am J Pathol 160 2002 433 440
24. M.L. Voz, J. Mathys, K. Hensen, H. Pendeville, I. Van Valckenborgh, and C. Van Huffel Microarray screening for target genes of the proto-oncogene PLAG1 Oncogene 23 1 2004 179 191
25. A.K. El-Naggar, D. Callender, M.M. Coombes, K. Hurr, M.A. Luna, and J.G. Batsakis Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer 27 2 2000 162 168
26. G. Henriksson, K.M. Westrin, B. Carlsöö, and C. Silfverswärd Recurrent primary pleomorphic adenomas of salivary gland origin. Intrasurgical rupture, histopathologic features, and pseudopodia Cancer 82 1998 617 620
27. E. Stennert, C. Wittekindt, J.P. Klussmann, G. Arnold, and O. Guntinas-Lichius Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study Laryngoscope 114 1 2004 148 163
28. A.T. Savera, and R.J. Zarbo Defining the role of myoepithelium in salivary gland neoplasia Adv Anat Pathol 11 2 2004 69 85
29. J.G. Batzakis, B. Kraemer, and J.J. Sciubba The pathology of head and neck tumors: the myoepithelial cell and its participation in salivary gland neoplasia, Part 17 Head Neck Surg 5 3 1983 222 233
30. P.C. Edwards, T. Bhuiya, and R.D. Kelsch Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 5 2004 613 619
31. A. Yang, M. Kaghad, Y. Wang, E. Gillett, M.D. Fleming, and V. Dötsch p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Molecular Cell 2 1998 305 316
32. N.A. Little, and A.G. Jochemsen P63 Int J Biochem Cell Biol 34 2002 6 9
33. M. Pia-Foschini, J.S. Reis-Filho, V. Eusebi, and S.R. Lakhani Salivary gland-like tumours of the breast: surgical and molecular pathology J Clin Pathol 56 2003 497 506
34. A.R. Prasad, A.T. Savera, A.M. Gown, and R.J. Zarbo The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma Arch Pathol Lab Med 123 1999 801 806
35. J.S. Reis-Filho, P.T. Simpson, A. Martins, A. Preto, F. Gartner, and F.C. Schmitt Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray Virchows Arch 443 2 2003 122 132
36. M.D. Stemlicht, P. Kedeshian, Z.M. Shao, S. Safarians, and S.H. Barsky The human myoepithelial cell is a natural tumor suppressor Clin Cancer Res 3 1977 1949 1958
37. A.N. Kalof, D. Tam, B. Beatty, and K. Cooper Immunostaining of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain J Clin Pathol 57 2004 625 629